Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Publisher Website

9 February 2021

journal article
correction
Published by Springer Science and Business Media LLC in Oncogene

Vol. 40 (11), 2147
https://doi.org/10.1038/s41388-021-01669-w

Abstract

No abstract available

This publication has 1 reference indexed in Scilit:

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Oncogene, 2020